These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
829 related articles for article (PubMed ID: 8649654)
1. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure. Attman PO; Alaupovic P; Tavella M; Knight-Gibson C Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654 [TBL] [Abstract][Full Text] [Related]
3. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins. Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484 [TBL] [Abstract][Full Text] [Related]
4. The compositional abnormalities of lipoproteins in diabetic renal failure. Attman PO; Knight-Gibson C; Tavella M; Samuelsson O; Alaupovic P Nephrol Dial Transplant; 1998 Nov; 13(11):2833-41. PubMed ID: 9829487 [TBL] [Abstract][Full Text] [Related]
5. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency. Lee DM; Knight-Gibson C; Samuelsson O; Attman PO; Wang CS; Alaupovic P Kidney Int; 2002 Jan; 61(1):209-18. PubMed ID: 11786103 [TBL] [Abstract][Full Text] [Related]
6. Progression of renal failure: role of apolipoprotein B-containing lipoproteins. Attman PO; Samuelsson O; Alaupovic P Kidney Int Suppl; 1997 Dec; 63():S98-101. PubMed ID: 9407433 [TBL] [Abstract][Full Text] [Related]
7. Lipoprotein composition in insulin-dependent diabetes mellitus with chronic renal failure: effect of kidney and pancreas transplantation. Hughes TA; Gaber AO; Amiri HS; Wang X; Elmer DS; Winsett RP; Hathaway DK; Hughes SM; Ghawji M Metabolism; 1994 Mar; 43(3):333-47. PubMed ID: 8139482 [TBL] [Abstract][Full Text] [Related]
8. The effect of decreasing renal function on lipoprotein profiles. Attman PO; Samuelsson O; Alaupovic P Nephrol Dial Transplant; 2011 Aug; 26(8):2572-5. PubMed ID: 21220758 [TBL] [Abstract][Full Text] [Related]
9. Kidney-pancreas transplantation. The effect of portal versus systemic venous drainage of the pancreas on the lipoprotein composition. Hughes TA; Gaber AO; Amiri HS; Wang X; Elmer DS; Winsett RP; Hathaway DK; Hughes SM Transplantation; 1995 Dec; 60(12):1406-12. PubMed ID: 8545865 [TBL] [Abstract][Full Text] [Related]
10. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia. Superko HR; Garrett BC; King SB; Momary KM; Chronos NA; Wood PD Am J Cardiol; 2009 Feb; 103(3):387-92. PubMed ID: 19166694 [TBL] [Abstract][Full Text] [Related]
11. Human intestinal lipoproteins. Studies in chyluric subjects. Green PH; Glickman RM; Saudek CD; Blum CB; Tall AR J Clin Invest; 1979 Jul; 64(1):233-42. PubMed ID: 221544 [TBL] [Abstract][Full Text] [Related]
12. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis. Attman PO; Alaupovic P Nephron; 1991; 57(4):401-10. PubMed ID: 2046821 [TBL] [Abstract][Full Text] [Related]
14. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome. Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis. Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020 [TBL] [Abstract][Full Text] [Related]
16. Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal disease. Samuelsson O; Attman PO; Knight-Gibson C; Kron B; Larsson R; Mulec H; Weiss L; Alaupovic P Nephron; 1997; 75(3):286-94. PubMed ID: 9069450 [TBL] [Abstract][Full Text] [Related]
17. Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects. Hughes TA; Stentz F; Gettys T; Smith SR Metabolism; 2006 Jan; 55(1):26-34. PubMed ID: 16324916 [TBL] [Abstract][Full Text] [Related]
18. Plasma remnant-like particle lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects. Marcoux C; Tremblay M; Fredenrich A; Jacques H; Krimbou L; Nakajima K; Davignon J; Cohn JS Atherosclerosis; 1998 Jul; 139(1):161-71. PubMed ID: 9699904 [TBL] [Abstract][Full Text] [Related]
19. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages. Milosavljevic D; Griglio S; Le Naour G; Chapman MJ Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449 [TBL] [Abstract][Full Text] [Related]